Hikma Pharmaceutical reported 1.34B in Sales Revenues for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Artemis Alpha ATS:LN -9335000 58.77M
AstraZeneca AZN:LN 11390M 621M
Bayer BAYN:GR € 14639M 3521M
Fresenius FRE:GR € 9720M 246M
Fresenius Medical Care FMS:US $ 4548.37M 98.66M
Galapagos GLPG:NA € 144.03M 40.36M
Genmab GEN:DC DK 2119M 500M
GlaxoSmithKline GSK:LN 9780M 253M
GRIFOLS GRF:SM € 1351.9M 167.16M
H. Lundbeck A/S LUN:DC 4.37B 319M
Hikma Pharmaceutical HIK:LN 1.34B 121M
Lonza Group LONN:SW 2.87B 325M
Merck MRK:GR € 5198M 15M
Orion ORNBV:FH € 270.6M 5.9M
Recordati REC:IM € 419.38M 4.5M
Roche Holding ROG:VX 16.44B 474M